Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 762 of 5804
-
New combo attack shows promise for Oligo-Metastatic lung cancer
Disease control OngoingA multicentre single arm phase II trial assessing the efficacy of immunotherapy, chemotherapy plus stereotactic radiotherapy to metastases followed by definitive surgery or radiotherapy to the locoregional primary tumour, in patients with histologically-confirmed synchronous olig…
Phase: PHASE2 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New trial aims to make stem cell transplants safer for blood cancer patients
Disease control Recruiting nowThis phase II trial investigates two strategies and how well they work for the reduction of graft versus host disease in patients with acute leukemia or MDS in remission. Giving chemotherapy and total-body irradiation before a donor peripheral blood stem cell transplant helps sto…
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug duo shows promise for Hard-to-Treat cancers
Disease control CompletedThe purpose of this study is to assess the efficacy and safety of treatment with olaparib (MK-7339) in combination with pembrolizumab (MK-3475) in adults with previously treated, advanced (metastatic and/or unresectable) Homologous Recombination Repair Mutation (HRRm) and/or Homo…
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New drug duo shows promise for tough bladder cancer
Disease control OngoingThis phase I/II trial studies the side effects and best dose of tazemetostat and how well it works when given together with pembrolizumab in treating patients with urothelial carcinoma that has spread to nearby tissue or lymph nodes (locally advanced ) or from where it first star…
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Ublituximab shows promise for Long-Term MS control in large extension trial
Disease control OngoingThe purpose of this study is to evaluate long-term safety and efficacy of ublituximab therapy in participants with relapsing multiple sclerosis (RMS).
Phase: PHASE3 • Sponsor: TG Therapeutics, Inc. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Healing the next generation: native american program aims to break cycle of trauma and suicide
Prevention CompletedThe overall goal of this study is to develop, adapt and evaluate an intergenerational prevention intervention, named "Wakȟáŋyeža (Little Holy One)," with Native American caregivers on a Northern Plains reservation and the caregivers' 2-to-5-year-old children. The intervention aim…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
Can zapping all spots of prostate cancer delay progression? PLATON trial aims to find out
Disease control OngoingThe purpose of this study is to compare the effects of ablative therapy (radiation or surgery) to all sites of disease combined with standard treatments on prostate cancer, compared to the standard or usual treatments used to treat this disease.
Phase: NA • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Could your own stem cells tame Crohn's?
Disease control Recruiting nowUnfortunately, some patients with Crohn's disease (CD) fail to respond to the best clinical treatments and some only experience temporary benefit. For severe Crohn's disease, there is an experimental treatment called "high dose immunoablation" followed by autologous hematopoietic…
Phase: PHASE1, PHASE2 • Sponsor: Cedars-Sinai Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Blood treatment could slash transfusion infections in half
Disease control CompletedThis is a prospective, randomized, double-blind, controlled study to determine the effectiveness of Mirasol-treated fresh whole blood (FWB) versus Standard-issue FWB for preventing transmission of transfusion-transmitted infections (TTIs). The incidence of pre-defined viral, bact…
Phase: PHASE3 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New daily injection could cut bleeding episodes in hemophilia
Disease control OngoingThis study will test how well a new medicine called concizumab works in the body of people with haemophilia A or B without inhibitors. The purpose is to show that concizumab can prevent bleeds in the body and is safe to use. Participants who usually only take medicine to treat bl…
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New drug targets Hard-to-Treat cancers in early trial
Disease control CompletedDF1001-001 is a study of a new molecule that targets natural killer (NK) cells and T-cell activation signals to specific receptors on cancer cells. The study will occur in two phases. The first phase will be a dose escalation phase, enrolling patients with various types of solid …
Phase: PHASE1, PHASE2 • Sponsor: Dragonfly Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Lung cancer trial: can radiation boost targeted drugs for limited metastases?
Disease control Recruiting nowA Phase II randomized controlled trial of TKI Alone versus TKI and Local Consolidative Radiation Therapy in oncogene driver mutated oligo metastatic Non-small cell lung cancer patients.
Phase: PHASE2 • Sponsor: Tata Memorial Hospital • Aim: Disease control
Last updated Jun 26, 2026 16:26 UTC
-
Magnetic pulses to the brain may help stroke survivors regain arm function
Disease control OngoingPaired associative stimulation (PAS) delivered with multi-channel deep transcranial magnetic stimulation (dTMS) may enhance motor recovery in patients with first-ever ischemic stroke. This study evaluates whether dTMS-PAS targeting both primary motor cortices (M1-M1) improves upp…
Phase: NA • Sponsor: Soroka University Medical Center • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Kids with CML may get a break from daily pills in new trial
Disease control OngoingThis phase II trial studies how stopping tyrosine kinase inhibitors will affect treatment-free remission in patients with chronic myeloid leukemia in chronic phase. When the level of disease is very low, it's called molecular remission. TKIs are a type of medication that help kee…
Phase: PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New hope for kidney transplant patients with cancer: drug combo aims to fight tumors without losing the donated kidney
Disease control OngoingThis phase I trial studies how well tacrolimus, nivolumab, and ipilimumab work in treating kidney transplant recipients with cancer that cannot be removed by surgery (unresectable) or has spread to other places in the body (metastatic). Tacrolimus may stop the growth of tumor cel…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug hopes to ease transfusion burden for kids with blood disorder
Disease control Recruiting nowThis is a Phase 2a study to evaluate the safety and pharmacokinetics (PK) of luspatercept in pediatric participants with β-thalassemia. The study will be conducted in 2 parts for both transfusion-dependent (TD) and non-transfusion-dependent (NTD) β-thalassemia participants: TD P…
Phase: PHASE2 • Sponsor: Celgene • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Stem cell trick may free kidney patients from daily pills
Disease control Recruiting nowThe purpose of this study is to find out if an investigational treatment will allow kidney transplant recipients to better accept their new kidney and stop immunosuppressive medicines. This study is for kidney transplant recipients who receive a kidney from a sibling donor. The …
Phase: PHASE1, PHASE2 • Sponsor: Jeffrey Veale, MD • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New combo therapy shows promise in reducing veteran suicides
Disease control CompletedHigh rates of Veteran suicide remain a tragedy. Rates of Veteran suicide have not decreased for 10 years, despite the best efforts of the field. Those interventions that do exist have only modest effects, which are simply insufficient for the magnitude of the problem. This propos…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 26, 2026 14:39 UTC
-
New combo therapy shows promise for tough liver cancer
Disease control OngoingA multicenter Phase II, randomized, prospective, open-label Trial investigating the clinical impact on combining Specific Internal Radiotherapy (SIRT) with the PD1-L Inhibitor Durvalumab and the CTLA-4 Inhibitor Tremelimumab in patients with intrahepatic Biliary Tract Cancer
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Can the HPV vaccine stop cervical abnormalities from returning after surgery?
Prevention CompletedThe researchers involved in this new study are interested in whether giving a HPV vaccine to women at the same time as conisation can lead to a greater rate of HPV clearance compared to conisation on its own, and a result reduce the occurrence of further infection and high grade …
Phase: PHASE3 • Sponsor: Imperial College London • Aim: Prevention
Last updated Jun 27, 2026 12:28 UTC